Entire Site
Articles/Fact Sheets
Ask the Experts
Conference Coverage
Now Live:
Breaking Research From AIDS 2008: Podcasts, Interviews, Videos & More >>
BROWSE TOPICS IN HIV TREATMENT:
HIV Treatment: Home Page
Just Diagnosed
HIV Medications
First Steps to Treatment
HIV Drug Resistance
Switching or Stopping Treatment
Third Line/Rescue Treatment
Hepatitis C Coinfection
Women & Pregnancy
HIV Treatment for Children
Side Effects & Health Problems
Research & Experimental Drugs
HIV Treatment in the Developing World
Non-Nucleoside Reverse Transcriptase Inhibitors
The Basics
|
Intelence (Etravirine, TMC125)
|
Rescriptor (Delavirdine)
|
Sustiva (Efavirenz, Stocrin)
|
Viramune (Nevirapine)
|
Research
|
NNRTIs in Development
The Basics
Characteristics of Non-Nucleoside Reverse Transcriptase Inhibitors (PDF)
(January 29, 2008)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines,
click here
(PDF).
From
AIDSinfo
Pharmacokinetics: The Non-Nukes -- The Two Major Players
(Winter 2004/2005)
Pharmacist Jean Lee explains how NNRTIs work, and how efavirenz and nevirapine might interact with other HIV meds.
To read PDF,
click here
In
Positively Aware
, from
Test Positive Aware Network
Summary of NNRTI Dosing and Administration Recommendations
(November 2001)
In
HEPP News
, from
Brown Medical School
Real Life Situations ...
(March 2001)
In
WISE Words
, from
Project Inform
Know Your HIV Drugs: NNRTIs
(June 1, 2000)
In
STEP Ezine
, from
Seattle Treatment Education Project